Gainers
Arbe Robotics Ltd. (NASDAQ: ARBE) gained 62.8% to $7.08. Arbe Robotics is expected to report its financial results for the fourth quarter on Thursday, March 2, 2023.
Ambrx Biopharma Inc. (NYSE: AMAM) surged 59% to $5.17. Ambrx Biopharma recently announced initial data from its ongoing Phase 1 APEX-01 trial of ARX517, Ambrx's proprietary anti-PSMA ADC, in prostate cancer patients.
Harbor Custom Development, Inc. (NASDAQ: HCDI) shares jumped 50.3% to $0.5260 after the company said it has contracted to sell mills Crossing townhomes for $14.25 million.
Mobilicom Limited (NASDAQ: MOB) shares gained 37.4% to $2.1307 after the company announced it has entered a strategic partnership with Mistral, a prime contractor for the US Department of Defense.
Sorrento Therapeutics, Inc. (NASDAQ: SRNE) jumped 33% to $0.4151.
LanzaTech Global, Inc. (NASDAQ: LNZA) gained 27.7% to $5.30.
Atlas Lithium Corporation (NASDAQ: ATLX) rose 25.4% to $9.05.
Chemomab Therapeutics Ltd. (NASDAQ: CMMB) jumped 25% to $2.45 after the company announced FDA clearance of its Investigational New Drug Application to evaluate CM-101 in a Phase 2 trial in adults with systemic sclerosis.
Zedge, Inc. (NYSE: ZDGE) rose 21.1% to $3.27. Zedge, during December, posted a Q1 loss of $0.01 per share.
Troika Media Group Inc (NASDAQ: TRKA) shares rose 20.6% to $0.2655 after dropping 4% on Friday.
Helix Energy Solutions Group, Inc. (NYSE: HLX) surged 17.7% to $8.98 after the company posted a profit for the fourth quarter.
Titan Medical Inc. (NASDAQ: TMDI) gained 16% to $0.2212.
Siyata Mobile Inc. (NASDAQ: SYTA) rose 14% to $0.1733. Siyata received $750,000 order for its next generation push-to-talk over cellular solution.
Travere Therapeutics, Inc. (NASDAQ: TVTX) jumped 13.6% to $20.24. The FDA granted accelerated approval to Travere Therapeutics’ Filspari (sparsentan) to reduce ...
Benzinga
